The Collectables: Year in Bioanalysis
authentic chemical standards for gen- erating reference data that can be used to unambiguously identify molecules. This is the single biggest limitation in these fields, and will be addressed in part by the NIH Common Fund Metabolomics Program which is investing approximately $5M per year over the next 4 years in projects that will develop innovative computa- tional approaches, coupled with experimental validation, to
greatly enhance compound identification of the most signifi- cant, biomedically-relevant unknown metabolites and chem- icals. If successful, these projects may very well revolution- ize how the community conducts metabolomics, exposomics and related studies.
Financial & competing
interests
d isclosure The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial con- flict with the subject matter or materials discussed in the manuscript. This includes employment, consultan- cies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this
manuscript.
Disclaimer The opinions expressed in this interview are those of the interviewee and do not necessarily reflect the views of Future Science Group.
www.bioanalysis-zone.com
47
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58
